Vibhavadi Medical Center PCL (BKK:VIBHA)
Thailand · Delayed Price · Currency is THB 1.360
0.00 (0.00%)
Feb 10, 2026, 11:45 AM ICT
BKK:VIBHA Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 8,234 | 8,548 | 8,173 | 8,612 | 7,373 | 6,024 |
Other Revenue | 135.53 | 129.81 | 144.67 | 154.33 | 107.69 | 123.95 |
| 8,370 | 8,678 | 8,318 | 8,767 | 7,481 | 6,148 | |
Revenue Growth (YoY) | -4.68% | 4.33% | -5.12% | 17.18% | 21.68% | -7.71% |
Cost of Revenue | 6,166 | 6,115 | 5,834 | 5,876 | 5,179 | 4,486 |
Gross Profit | 2,204 | 2,563 | 2,484 | 2,891 | 2,302 | 1,663 |
Selling, General & Admin | 1,375 | 1,385 | 1,187 | 1,089 | 934.88 | 925.04 |
Operating Expenses | 1,375 | 1,385 | 1,187 | 1,089 | 934.88 | 925.04 |
Operating Income | 829.19 | 1,178 | 1,298 | 1,801 | 1,367 | 737.48 |
Interest Expense | -336.78 | -344.62 | -306.34 | -244.81 | -206.04 | -202.72 |
Interest & Investment Income | 320.43 | 319.72 | 360.27 | 375.97 | 342.43 | 192.09 |
Earnings From Equity Investments | 89.83 | 65.9 | 73.74 | 135.71 | 721.69 | -62.35 |
EBT Excluding Unusual Items | 902.66 | 1,219 | 1,425 | 2,068 | 2,225 | 664.5 |
Gain (Loss) on Sale of Investments | -460.36 | -214.93 | -153.87 | -100.23 | -11.23 | 19.59 |
Gain (Loss) on Sale of Assets | -0.41 | -0.41 | - | -14.91 | - | -2.24 |
Pretax Income | 491.89 | 1,004 | 1,271 | 1,953 | 2,214 | 681.85 |
Income Tax Expense | 149.74 | 164.76 | 196.84 | 302.02 | 224.39 | 127.66 |
Earnings From Continuing Operations | 342.15 | 839.1 | 1,075 | 1,651 | 1,989 | 554.19 |
Earnings From Discontinued Operations | - | - | - | -35.89 | -38.36 | - |
Net Income to Company | 342.15 | 839.1 | 1,075 | 1,615 | 1,951 | 554.19 |
Minority Interest in Earnings | 46.64 | -140.49 | -209.38 | -275.49 | -146.06 | -88.72 |
Net Income | 388.79 | 698.61 | 865.12 | 1,340 | 1,805 | 465.47 |
Net Income to Common | 388.79 | 698.61 | 865.12 | 1,340 | 1,805 | 465.47 |
Net Income Growth | -62.02% | -19.25% | -35.43% | -25.78% | 287.79% | -42.47% |
Shares Outstanding (Basic) | 13,485 | 13,523 | 13,576 | 13,576 | 13,576 | 13,414 |
Shares Outstanding (Diluted) | 13,485 | 13,523 | 13,576 | 13,576 | 14,887 | 14,783 |
Shares Change (YoY) | -0.45% | -0.39% | - | -8.81% | 0.71% | 0.41% |
EPS (Basic) | 0.03 | 0.05 | 0.06 | 0.10 | 0.13 | 0.03 |
EPS (Diluted) | 0.03 | 0.05 | 0.06 | 0.10 | 0.12 | 0.03 |
EPS Growth | -61.85% | -18.93% | -35.43% | -18.59% | 284.85% | -42.73% |
Free Cash Flow | 798.38 | 1,202 | 1,312 | 1,545 | 714.83 | -393.73 |
Free Cash Flow Per Share | 0.06 | 0.09 | 0.10 | 0.11 | 0.05 | -0.03 |
Dividend Per Share | 0.050 | 0.050 | 0.050 | 0.055 | 0.050 | 0.040 |
Dividend Growth | - | - | -9.09% | 10.00% | 25.00% | -11.11% |
Gross Margin | 26.33% | 29.54% | 29.86% | 32.97% | 30.77% | 27.04% |
Operating Margin | 9.91% | 13.58% | 15.60% | 20.55% | 18.27% | 12.00% |
Profit Margin | 4.64% | 8.05% | 10.40% | 15.28% | 24.13% | 7.57% |
Free Cash Flow Margin | 9.54% | 13.85% | 15.78% | 17.62% | 9.55% | -6.40% |
EBITDA | 1,437 | 1,800 | 1,932 | 2,410 | 1,837 | 1,142 |
EBITDA Margin | 17.17% | 20.74% | 23.22% | 27.49% | 24.56% | 18.57% |
D&A For EBITDA | 607.61 | 621.57 | 634.01 | 608.32 | 470.09 | 404.5 |
EBIT | 829.19 | 1,178 | 1,298 | 1,801 | 1,367 | 737.48 |
EBIT Margin | 9.91% | 13.58% | 15.60% | 20.55% | 18.27% | 12.00% |
Effective Tax Rate | 30.44% | 16.41% | 15.48% | 15.46% | 10.14% | 18.72% |
Revenue as Reported | 8,740 | 8,998 | 8,678 | 9,065 | 7,845 | 6,358 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.